MedPath

TO EVALUATE THE CLINICAL EFFICACY OF OF ASANATWAK LEPA IN AHIPUTANA(Napkin Rash)

Phase 3
Conditions
Health Condition 1: L22- Diaper dermatitis
Registration Number
CTRI/2023/05/052575
Lead Sponsor
Ramesh G Halalli
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children with 2 or more symptoms among the diagnostic criteria will be selected for the study.

H/O of symptoms of AHIPUTANA/ Napkin Rash not more than 7 days.

Exclusion Criteria

Children suffering from any other systemic disorders.

Children who have other generalised skin infections other than AHIPUTANA.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath